Welcome to the December 2017 edition of the Clinical Communiqué. For the final edition of the year, we have chosen to present a selection of cases that demonstrate some of the important non-clinical aspects of coronial investigations and inquest findings.
Welcome to the September edition of the Clinical Communiqué. This edition marks three years and a dozen publications since the launch of our series. Over that time, we have looked at many themes central for improving safe and timely care to patients, including the importance of recognising the deteriorating patient, teamwork and communication, and effective decision-making. Medications represent another area where safety issues such as prescribing practices and modes of medication delivery are critical in many cases of avoidable patient deaths.
Following the discussion on patient-controlled-analgesia (PCA) in our June issue of the Clinical Communiqué, we present a supplementary expert commentary with pertinent clinical advice for our readers on the use of oral opioids with PCAs.
Welcome to the winter 2017 edition of the Clinical Communiqué. Since our last edition, we have seen interest in our publication continue to grow, and we have been heartened by the feedback we continue to receive from our readers about the lessons learned.
The primary aim of this study was to explore whether subscribers reported clinical practice changes as a result of reading the CC. It also compared the characteristics of subscribers who self-reported changes to clinical practice with those who did not, and explores subscribers’ perceptions of the educational value of the CC.
In this issue of the Clinical Communiqué, we focus on PE as the single, specific cause of death. As featured in the three cases presented, PE is a diagnosis that can occur in any healthcare setting, from general practice, to the emergency department, to the postoperative ward. It is a diagnosis that every healthcare practitioner needs to be familiar with to adequately detect and treat it in their patients, every time.